MADELEINE VALENCERINA: Open Payments
NPI 1437284809 · LA MIRADA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 7 payments from 3 companies in 2025. Trend: 2023 $521 · 2024 $232 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $260 |
| Janssen Pharmaceuticals, Inc | 3 | $237 |
| Teva Pharmaceuticals USA, Inc. | 2 | $114 |
Products named: ARISTADA, LYBALVI, INVEGA SUSTENNA, INVEGA TRINZA, UZEDY.
Industry payments across CA — which companies pay providers there.
